The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus-Reference-Cited by-同舟云学术

The strategies for treating primary hepatocellular carcinoma with portal vein tumor thrombus

Published:2015-08 Issue: Volume:20 Page:8-16
ISSN:1743-9191
Container-title:International Journal of Surgery
language:en
Short-container-title:International Journal of Surgery

Author:

Zhang Zong-ming,Lai Eric C.H.,Zhang Chong,Yu Hong-wei,Liu Zhuo,Wan Bo-jiang,Liu Li-min,Tian Zu-hao,Deng Hai,Sun Qiu-hong,Chen Xiao-ping

Funder

National Natural Science Foundation of China

Science and Technology Project of State Grid Corporation of China

Publisher

Elsevier BV

Subject

General Medicine,Surgery

Reference64 articles.

1. Global cancer statistics, 2012;Torre;CA Cancer J. Clin.,2015

2. Hepatocellular carcinoma with portal vein tumor thrombosis: clinical characteristics, prognosis, and patient survival analysis;Takizawa;Dig. Dis. Sci.,2007

3. An aggressive approach leads to improved survival in hepatocellular carcinoma patients with portal vein tumor thrombus;Lin;J. Cancer Res. Clin. Oncol.,2011

4. Tumor thrombus types influence the prognosis of hepatocellular carcinoma with the tumor thrombi in the portal vein;Cheng;Hepatogastroenterology,2007

5. A new classification for hepatocellular carcinoma portal vein tumor thrombus;Shi;J. Hepatobiliary Pancreat. Sci.,2011

Cited by 147 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiotherapy with targeted and immunotherapy improved overall survival and progression-free survival for hepatocellular carcinoma with portal vein tumor thrombosis;The Oncologist;2024-09-04

2. Portal vein tumor thrombosis in hepatocellular carcinoma patients: Is it the end?;Liver Research;2024-09

3. Neoadjuvant-Based Triple Therapy for Hepatocellular Carcinoma with Type I/II Portal Vein Tumor Thrombosis;Journal of Hepatocellular Carcinoma;2024-08

4. Research Progress in Predicting Hepatocellular Carcinoma with Portal Vein Tumour Thrombus in the Era of Artificial Intelligence;Journal of Hepatocellular Carcinoma;2024-07

5. Interventional therapy combined with tyrosine kinase inhibitors with or without immune checkpoint inhibitors as initial treatment for hepatocellular carcinoma with portal vein tumor thrombosis: a systematic review and meta-analysis;Discover Oncology;2024-05-14